Lisez les dernières nouvelles officielles de l'OMS et du CDC, répertoriées ci-dessous dans la section Flux d'actualités, en commençant par les plus récentes. Voyez les avis des deux organisations cartographiés au niveau mondial immédiatement ci-dessous.**
Flambées épidémiques de l'OMS
Human infection with avian influenza A (H5N8) – the Russian Fe...
Fri, 26 Feb 2021On 18 February 2021, the National IHR Focal Point for the Russian Federation notified WHO of detection of avian influenza A(H5N8) in seven human clinical specimens. These are the first reported detection of avian influenza A(H5N8) in humans. Positive clinical specimens were collected from poultry farm workers who participated in a response operation to contain an avian influenza A(H5N8) outbreak detected in a poultry farm in Astrakhan Oblast in the Russian Federation. The laboratory confirmation of the seven specimens were performed by the State Research Centre for Virology and Biotechnology VECTOR (WHO H5 Reference Laboratory). The age of seven positive cases ranged between 29 to 60 years and five were female.
Between 3 and 11 December, a total of 101 000 of 900 000 egg laying hens on the farm died. This high mortality rate prompted an investigation. Samples were collected from these birds and an initial detection of avian influenza A(H5N8) was performed by the Russian regional veterinary laboratory. On 11 December, the outbreak was confirmed by the World Organisation for Animal Health (OIE) Reference laboratory, and the Federal Centre for Animal Health (FGBI-ARRIAH), in Vladimir, the Russian Federation. Outbreak containment operations started immediately and continued for several days due to the large size of the poultry farm.
Ebola virus disease – Guinea...
Wed, 17 Feb 2021On 14 February 2021, the Ministry of Health (MoH) of Guinea informed WHO of a cluster of Ebola Virus
Rift Valley fever – Kenya...
Fri, 12 Feb 2021Rift Valley fever (RVF) has been reported in Kenya in humans in Isiolo and Mandera counties and in
Notices de voyage du CDC:
COVID-19 Low - COVID-19 in Samoa...
Mon, 19 Apr 2021If you travel, take steps before, during, and after travel to keep yourself and others from getting COVID-19.
COVID-19 Unknown - COVID-19 in Burundi ...
Mon, 19 Apr 2021Travelers should avoid all travel to Burundi.
COVID-19 High - COVID-19 in Sint Maarten...
Mon, 19 Apr 2021Travelers should avoid all nonessential travel to Sint Maarten.
COVID-19 Moderate - COVID-19 in Belize...
Mon, 19 Apr 2021Travelers at increased risk for severe illness from COVID-19 should avoid all nonessential travel to Belize.
COVID-19 Unknown - COVID-19 in Uzbekistan...
Mon, 19 Apr 2021Travelers should avoid all travel to Uzbekistan.
Cliquez ici pour rechercher des maladies liées aux voyages par nation.
Rapport hebdomadaire de la morbidité et de la mortalité (MMWR) du CDC:
QuickStats: Age-Adjusted Percentage of Adults Aged 25-64 Years Wh...
Thu, 15 Apr 2021This report describes the percentage of adults aged 25-64 who are worried about their ability to pay medical bills if they get sick or have an accident.
COVID-19 Stats: COVID-19 and Influenza Discharge Diagnoses as a P...
Thu, 15 Apr 2021This report describes the percentage of emergency department visits attributed to COVID-19 and influenza diagnoses.
Mises à jour actuelles du journalSkip Mises à jour actuelles du journal
Clinical Infectious Diseases Journal
This list includes items from the latest issue of the Clinical Infectious Diseases Journal.
Reply to Yamaoka, et al...
Thu, 08 Apr 2021To the Editor—We thank Yamaoka and colleagues for their interest and comments on our paper . Yamaoka et al point out that there are cross-reactivities of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) full-length nucleoprotein (FL-NP) with antibodies to other common human coronaviruses (HCoVs), which may cause false positive results in serological assays. They propose to use a truncated version of NP lacking the N-terminal (ΔNP) to detect SARS-CoV-2 antibodies.
Infectious Diseases Society of America Guidance on the Treatment ...
Thu, 08 Apr 2021AbstractBackgroundAntimicrobial-resistant infections are commonly encountered in US hospitals and result in significant morbidity and mortality. This guidance document provides recommendations for the treatment of infections caused by extended-spectrum β-lactamase–producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa).MethodsA panel of 6 infectious diseases specialists with expertise in managing antimicrobial-resistant infections formulated common questions regarding the treatment of ESBL-E, CRE, and DTR-P. aeruginosa infections. Based on review of the published literature and clinical experience, the panel provide recommendations and associated rationale for each recommendation. Because of significant differences in the molecular epidemiology of resistance and the availability of specific anti-infective agents globally, this document focuses on treatment of antimicrobial-resistant infections in the United States.ResultsApproaches to empiric treatment selection, duration of therapy, and other management considerations are briefly discussed. The majority of guidance focuses on preferred and alternative treatment recommendations for antimicrobial-resistant infections, assuming that the causative organism has been identified and antibiotic susceptibility testing results are known. Treatment recommendations apply to both adults and children.ConclusionsThe field of antimicrobial resistance is dynamic and rapidly evolving, and the treatment of antimicrobial-resistant infections will continue to challenge clinicians. This guidance document is current as of 17 September 2020. Updates to this guidance document will occur periodically as new data emerge. Furthermore, the panel will expand recommendations to include other problematic gram-negative pathogens in future versions. The most current version of the guidance including the date of publication can be found at www.idsociety.org/practice-guideline/amr-guidance/.
An Uncommon Cause of Chronic Cough...
Thu, 08 Apr 2021A 48-year-old female with no past medical history presented to the emergency department in June 2020 with a 6-month history of productive cough associated with nausea, vomiting, and 20-kg weight loss. She had no other symptoms. She lived in mainland France for 20 years, and had been living in Martinique for the past 9 years. She works as a caregiver, and her husband is a goat breeder. She has a dog and a cat. At clinical examination, the patient had no fever and no evidence of respiratory distress. She had a normal oxygen saturation. Heart and lung auscultation were unremarkable. The rest of the examination was normal. The peripheral white blood cell count was 5.84 G/L, of which 0.42 G/L were eosinophils. A mild normochromic normocytic anemia (hemoglobin, 11.6 g/dL) was found. There was no thrombocytopenia, and the C-reactive protein level was <3 mg/L. Liver and kidney function markers were also within normal ranges. Computed tomography of the chest revealed a ground-glass opacity at the base of the middle lobe (Figure 1). A bronchoscopy was performed. Bronchial mucosa appeared to be slightly inflamed with yellowish mucous secretions. During exploration of the right basal pyramid, the endoscopist found and removed a Y-shaped whitish–red motile body. The entire structure was sent to the parasitology laboratory for further identification (Figure 2).
Écoute: New England Journal of Medicine
The New England Journal of Medicine is a weekly general medicine journal, and this audio news feed presents interviews with specialists.
Vaccine Successes and Vaccine Adverse Events...
Wed, 14 Apr 2021Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, L.R. Baden, and S. Morrissey. Audio Interview: Vaccine Successes and Vaccine Adverse Events. N Engl J Med 2021;384:e70.
NEJM Interview: Dr. Andrew Ryan on new legislation to prevent pat...
Wed, 14 Apr 2021Dr. Andrew Ryan is the director of the Center for Evaluating Health Reform at the University of Michigan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. K.R. Chhabra, E. Fuse Brown, and A.M. Ryan. No More Surprises — New Legislation on Out-of-Network Billing. N Engl J Med 2021;384:1381-1383.
Antibody Responses to Natural Infection and Vaccination...
Wed, 07 Apr 2021Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, L.R. Baden, and S. Morrissey. Audio Interview: Antibody Responses to Natural Infection and Vaccination. N Engl J Med 2021;384:e65.
Emerging Infectious Diseases Journal:
This list contains articles published online ahead of print.
Respiratory Viral Shedding in Healthcare Workers Reinfected with ...
Mon, 19 Apr 2021M. R. Amorim et al.
Racial and Ethnic Disparities in Incidence of SARS-CoV-2 Infectio...
Thu, 15 Apr 2021N. D. Hollis et al.
Severe Acute Respiratory Syndrome Coronavirus 2 Serial Interval V...
Thu, 15 Apr 2021I. G. Reed et al.
Center for Infectious Disease Research and Policy:
News from the University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP).
All US adults now eligible for COVID-19 vaccine...
Mon, 19 Apr 2021
Global COVID pace hits new high as deaths top 3 million...
Mon, 19 Apr 2021
COVID-19 Scan for Apr 19, 2021...
Mon, 19 Apr 2021COVID-19 spread in schoolsCOVID vaccine & blood cancers
Johns Hopkins Medicine RSS Feed:
Johns Hopkins Medicine science and medical news.
Study Shows Increased Risk of Uterine Fibroids in African-America...
Thu, 28 Dec 2017
In a study of medical records gathered on hundreds of thousands of African-American women, Johns Hopkins researchers say they have evidence that women with a common form of hair loss have an increased chance of developing uterine leiomyomas, or fibroids.
More Tumor Mutations Equals Higher Success Rate With Cancer Immun...
Wed, 20 Dec 2017
The “mutational burden,” or the number of mutations present in a tumor’s DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by
Johns Hopkins Kimmel Cancer Centerresearchers shows. The finding, published in the Dec. 21 New England Journal of Medicine, could be used to guide future clinical trials for these drugs.
How Electroconvulsive Therapy Relieves Depression Per Animal Expe...
Mon, 18 Dec 2017
In a study using genetically engineered mice, Johns Hopkins researchers have uncovered some new molecular details that appear to explain how electroconvulsive therapy (ECT) rapidly relieves severe depression in mammals, presumably including people. The molecular changes allow more communication between neurons in a specific part of the brain also known to respond to antidepressant drugs.
American Journal of Infection Control:
RSS feed including 'the latest published articles, both published in an issue and published as Articles in Press.'
The Impact of Infections on Reimbursement in 92 US Hospitals, 20...
2021-04-20The diagnosis-related group (DRG) system was introduced to US Medicare in 1983 as a way to standardize healthcare payments by replacing retrospective payment systems that reward high volumes of care with a prospective payment system that reimburses hospitals based on a predetermined amount for that admission category, regardless of the resources used for any particular patient.1,2 Currently, DRGs serve as the basis for reimbursement for hospitalized patients by Medicare and many private payers. The system has evolved over the years to account for a variety of modifiers including geographic area, primary and secondary diagnoses, disease severity, and value-based incentives, to name a few.
Association between Influenza Vaccination and severe COVID-19 ou...
2021-04-20In the United States, the Coronavirus disease-2019 (COVID-19) pandemic has resulted in 31.3 million confirmed cases and over 562,000 deaths as of April 13, 2021.1 Experts had warned of a possible second wave in late fall and winter, corresponding with the influenza (flu) season. Influenza co-infection with COVID-19 brings with it challenges of clinically distinguishing both infectious agents, test cross-reactivity and accuracy; and possibly enhancing the risk for severe COVID-19. This can significantly affect downstream public health efforts to properly identify COVID-19 cases and contain the outbreak particularly in resource-limited settings.
A cluster of Achromobacter xylosoxidans led to identification of...
2021-04-18A cluster of Achromobacter xylosoxidans, an emerging multidrug-resistant aquaphilic bacterium, was identified in three long-term–care facility residents. As Pseudomonas aeruginosa and Serratia marcescens were also present in clinical specimens, we conducted an investigation of all three water-associated species and identified P. aerguniosa and S. marcesens contamination at the facility. Sequencing analysis linked P. aeruginosa to a clinical isolate. Findings highlight the need for precautionary measures to prevent transmission of water-associated multidrug-resistant bacteria in long-term–care facilities.